α1-Fetoprotein transcription factor (FTF)/liver receptor homolog-1 (LRH-1) is an essential lipogenic regulator

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1801, Issue 4, 2010, Pages 473-479

  Xu, Zhumei ^a   Ouyang, Lingli ^a   del Castillo Olivares, Antonio ^a   Pandak, William M ^a   Gil, Gregorio ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bile acid; Cholesterol; Knockout mice; Nuclear receptor; Triglyceride

Indexed keywords

ALPHA FETOPROTEIN; ALPHA FETOPROTEIN TRANSCRIPTION FACTOR; CHENODEOXYCHOLIC ACID; CHOLESTEROL; LIVER RECEPTOR HOMOLOG 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ARTICLE; CHOLESTEROL BLOOD LEVEL; GENE REPRESSION; GENE TARGETING; HOMEOSTASIS; LIPID METABOLISM; LIPOGENESIS; LOBELIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRIACYLGLYCEROL BLOOD LEVEL;

ADENOVIRIDAE; ANIMALS; BLOTTING, WESTERN; CHENODEOXYCHOLIC ACID; CHOLESTEROL; DNA-BINDING PROTEINS; GASTROINTESTINAL AGENTS; HOMEOSTASIS; LIPOPROTEINS, HDL; LIVER; MALE; MICE; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRIGLYCERIDES;

MUS;

EID: 76549114111     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2009.12.009     Document Type: Article

References (53)

1. Fayard E., Auwerx J., and Schoonjans K. LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis. Trends Cell Biol. 14 (2004) 250-260
2. Falender A.E., Lanz R., Malenfant D., Belanger L., and Richards J.S. Differential expression of steroidogenic factor-1 and FTF/LRH-1 in the rodent ovary. Endocrinology 144 (2003) 3598-3610
3. Li Y., Choi M., Cavey G., Daugherty J., Suino K., Kovach A., et al. Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1. Mol. Cell 17 (2005) 491-502
4. 1-fetoprotein transcription factor/LRH-1 in bile acid biosynthesis: a known nuclear receptor activator that can act as a suppressor of bile acid biosynthesis. J. Biol. Chem. 279 (2004) 16813-16821
5. Pare J.F., Malenfant D., Courtemanche C., Jacob-Wagner M., Roy S., Allard D., et al. The fetoprotein transcription factor (FTF) gene is essential to embryogenesis and cholesterol homeostasis and is regulated by a DR4 element. J. Biol. Chem. 279 (2004) 21206-21216
6. 1-fetoprotein transcription factor is required for the expression of sterol 12a-hydroxylase, the specific enzyme for cholic acid synthesis. J. Biol. Chem. 275 (2000) 17793-17799
7. Bohan A., Chen W.S., Denson L.A., Held M.A., and Boyer J.L. Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis. J. Biol. Chem. 278 (2003) 36688-36698
8. Inokuchi A., Hinoshita E., Iwamoto Y., Kohno K., Kuwano M., and Uchiumi T. Enhanced expression of the human multidrug resistance protein 3 by bile salt in human enterocytes. A transcriptional control of a plausible bile acid transporter. J. Biol. Chem. 276 (2001) 46822-46829
9. Chen F., Ma L., Dawson P.A., Sinal C.J., Sehayek E., Gonzalez F.J., et al. Liver receptor homologue-1 mediates species- and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporter. J. Biol. Chem. 278 (2003) 19909-19916
10. Luo Y., Liang C.P., and Tall A.R. The orphan nuclear receptor LRH-1 potentiates the sterol-mediated induction of the human CETP gene by liver X receptor. J. Biol. Chem. 276 (2001) 24767-24773
11. Delerive P., Galardi C.M., Bisi J.E., Nicodeme E., and Goodwin B. Identification of liver receptor homolog-1 as a novel regulator of apolipoprotein AI gene transcription. Mol. Endocrinol. 18 (2004) 2378-2387
12. Schoonjans K., Annicotte J.S., Huby T., Botrugno O.A., Fayard E., Ueda Y., et al. Liver receptor homolog 1 controls the expression of the scavenger receptor class B type I. EMBO Reports 3 (2002) 1181-1187
13. Freeman L.A., Kennedy A., Wu J., Bark S., Remaley A.T., Santamarina-Fojo S., et al. The orphan nuclear receptor LRH-1 activates the ABCG5/ABCG8 intergenic promoter. J. Lipid Res. 45 (2004) 1197-1206
14. Venteclef N., Haroniti A., Tousaint J.J., Talianidis I., and Delerive P. Regulation of anti-atherogenic apolipoprotein M gene expression by the orphan nuclear receptor LRH-1. J. Biol. Chem. 283 (2008) 3694-3701
15. Matsukuma K.E., Wang L., Bennett M.K., and Osborne T.F. A key role for orphan nuclear receptor liver receptor homologue-1 in activation of fatty acid synthase promoter by liver X receptor. J. Biol. Chem. 282 (2007) 20164-20171
16. Huang J., Iqbal J., Saha P.K., Liu J., Chan L., Hussain M.M., et al. Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver. Hepatology 46 (2007) 147-157
17. Botrugno O.A., Fayard E., Annicotte J.S., Haby C., Brennan T., Wendling O., et al. Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation. Mol. Cell 15 (2004) 499-509
18. Schoonjans K., Dubuquoy L., Mebis J., Fayard E., Wendling O., Haby C., et al. Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 2058-2062
19. Clyne C.D., Speed C.J., Zhou J., and Simpson E.R. Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes. J. Biol. Chem. 277 (2002) 20591-20597
20. Kim J.W., Peng N., Rainey W.E., Carr B.R., and Attia G.R. Liver receptor homolog-1 regulates the expression of steroidogenic acute regulatory protein in human granulosa cells. J. Clin. Endocr. Metab. 89 (2004) 3042-3047
21. Saxena D., Safi R., Little-Ihrig L., and Zeleznik A.J. Liver receptor homolog-1 stimulates the progesterone biosynthetic pathway during follicle-stimulating hormone-induced granulosa cell differentiation. Endocrinology 145 (2004) 3821-3829
22. Zhou L.Y., Wang D.S., Shibata Y., Paul-Prasanth B., Suzuki A., and Nagahama Y. Characterization, expression and transcriptional regulation of P450c17-I and -II in the medaka, Oryzias latipes. Biochem. Biophysic. Res. Commun. 362 (2007) 619-625
23. Sirianni R., Seely J.B., Attia G., Stocco D.M., Carr B.R., Pezzi V., et al. Liver receptor homologue-1 is expressed in human steroidogenic tissues and activates transcription of genes encoding steroidogenic enzymes. J. Endocrinol. 174 (2002) R13-R17
24. Labelle-Dumais C., Pare J.F., Belanger L., Farookhi R., and Dufort D. Impaired progesterone production in Nr5a2+/- mice leads to a reduction in female reproductive function. Biol. Reprod. 77 (2007) 217-225
25. Glass C.K., and Witztum J.L. Atherosclerosis. The road ahead. Cell 104 (2001) 503-516
26. Chinetti-Gbaguidi G., and Staels B. Lipid ligand-activated transcription factors regulating lipid storage and release in human macrophages. Biochim. Biophys. Acta 1791 (2009) 486-493
27. McKenna N.J., Cooney A.J., DeMayo F.J., Downes M., Glass C.K., Lanz R.B., et al. Minireview: evolution of NURSA, the nuclear receptor signaling atlas. Mol. Endocrinol. 23 (2009) 740-746
28. Wang M., and Tafuri S. Modulation of PPARgamma activity with pharmaceutical agents: treatment of insulin resistance and atherosclerosis. J. Cell. Biochem. 89 (2003) 38-47
29. Xu Z., Tavares-Sanchez O.L., Li Q., Fernando J., Rodriguez C.M., Studer E.J., et al. Activation of bile acid biosynthesis by the p38 mitogen-activated protein kinase (MAPK): hepatocyte nuclear factor-4alpha phosphorylation by the p38 MAPK is required for cholesterol 7alpha-hydroxylase expression. J. Biol. Chem. 282 (2007) 24607-24614
30. Folch J., Lees M., and Sloane-Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226 (1957) 497-509
31. Mataki C., Magnier B.C., Houten S.M., Annicotte J.S., Argmann C., Thomas C., et al. Compromised intestinal lipid absorption in mice with a liver-specific deficiency of the Liver Receptor Homolog 1. Mol. Cell. Biol. (2007) 2007
32. Horton J.D., Shimomura I., Ikemoto S., Bashmakov Y., and Hammer R.E. Overexpression of sterol regulatory element-binding protein-1a in mouse adipose tissue produces adipocyte hypertrophy, increased fatty acid secretion, and fatty liver. J. Biol. Chem. 278 (2003) 36652-36660
33. Angelin B., Einarsson K., Hellstrom K., and Leijd B. Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia. J. Lipid Res. 19 (1978) 1017-1024
34. Di Mario F., Angonese C., Del Favero G., Aggio L., Meggiato T., Scalon P., et al. Changes in the pattern of serum biliary acids and lipoprotein picture during therapy with biliary acids in cholesterol lithiasis. G. Clin. Med. 71 (1990) 435-441
35. Watanabe M., Houten S.M., Wang L., Moschetta A., Mangelsdorf D.J., Heyman R.A., et al. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J. Clin. Invest. 113 (2004) 1408-1418
36. Foufelle F., and Ferre P. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem. J. 366 (2002) 377-391
37. Sato R., Okamoto A., Inoue J., Miyamoto W., Sakai Y., Emoto N., et al. Transcriptional regulation of the ATP citrate-lyase gene by sterol regulatory element-binding proteins. J. Biol. Chem. 275 (2000) 12497-12502
38. Shimano H., Horton J.D., Shimomura I., Hammer R.E., Brown M.S., and Goldstein J.L. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J. Clin. Invest. 99 (1997) 846-854
39. Koo S.H., Dutcher A.K., and Towle H.C. Glucose and insulin function through two distinct transcription factors to stimulate expression of lipogenic enzyme genes in liver. J. Biol. Chem. 276 (2001) 9437-9445
40. Magana M.M., and Osborne T.F. Two tandem binding sites for sterol regulatory element binding proteins are required for sterol regulation of fatty-acid synthase promoter. J. Biol. Chem. 271 (1996) 32689-32694
41. Horton J.D., Goldstein J.L., and Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109 (2002) 1125-1131
42. Bennett M.K., Lopez J.M., Sanchez H.B., and Osborne T.F. Sterol regulation of fatty acid synthase promoter. Coordinate feedback regulation of two major lipid pathways. J. Biol. Chem. 270 (1995) 25578-25583
43. Repa J.J., Liang G., Ou J., Bashmakov Y., Lobaccaro J.M., Shimomura I., et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev. 14 (2000) 2819-2830
44. Schultz J.R., Tu H., Luk A., Repa J.J., Medina J.C., Li L., et al. Role of LXRs in control of lipogenesis. Genes Dev. 14 (2000) 2831-2838
45. Yu L., Hammer R.E., Li-Hawkins J., Von Bergmann K., Lutjohann D., Cohen J.C., et al. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 16237-16242
46. Lee Y.K., Schmidt D.R., Cummins C.L., Choi M., Peng L., Zhang Y., et al. Liver receptor homolog-1 regulates bile acid homeostasis but is not essential for feedback regulation of bile acid synthesis. Mol. Endocrinol. 22 (2008) 1345-1356
47. Wolfrum C., Poy M.N., and Stoffel M. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat. Med. 11 (2005) 418-422
48. Kozarsky K.F., Donahee M.H., Rigotti A., Iqbal S.N., Edelman E.R., and Krieger M. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 387 (1997) 414-417
49. Varban M.L., Rinninger F., Wang N., Fairchild-Huntress V., Dunmore J.H., Fang Q., et al. Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 4619-4624
50. Zhang Y., Da Silva J.R., Reilly M., Billheimer J.T., Rothblat G.H., and Rader D.J. Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo. J. Clin. Invest. 115 (2005) 2870-2874
51. Carulli N., Ponz de Leon M., Podda M., Zuin M., Strata A., Frigerio G., et al. Chenodeoxycholic acid and ursodeoxycholic acid effects in endogenous hypertriglyceridemias. A controlled double-blind trial. J. Clin. Pharmacol. 21 (1981) 436-442
52. Goodwin B., Jones S.A., Price R.R., Watson M.A., McKee D.D., Moore L.B., et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell 6 (2000) 517-526
53. Lu T.T., Makishima M., Repa J.J., Schoonjans K., Kerr T.A., Auwerx J., et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell 6 (2000) 507-515